Showing results (221-230 of 340) with videos related to

Sort By:
Pageof 34
Journal of the American Society of Nephrology : JASN|July 23, 2020
Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS ProgramMegumi Oshima, Bruce Neal, Tadashi Toyama, et al.
The Lancet. Diabetes & Endocrinology|November 11, 2018
Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trialDick de Zeeuw, Ronny W Renfurm, George Bakris, et al.
Diabetes, Obesity & Metabolism|January 26, 2017
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trialBruce Neal, Vlado Perkovic, David R Matthews, et al.
Cardiovascular Diabetology|September 16, 2023
Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney diseaseJ David Smeijer, Donald E Kohan, Peter Rossing, et al.
Circulation|March 13, 2018
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS ProgramKarin Rådholm, Gemma Figtree, Vlado Perkovic, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 19, 2018
Effects of Dapagliflozin on Circulating Markers of Phosphate HomeostasisMaarten A de Jong, Sergei I Petrykiv, Gozewijn D Laverman, et al.
Diabetes, Obesity & Metabolism|July 13, 2019
Renal hyperfiltration defined by high estimated glomerular filtration rate: A risk factor for cardiovascular disease and mortalityMehmet Kanbay, Lale A Ertuglu, Baris Afsar, et al.
European Heart Journal|March 23, 2011
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trialsFrank A Holtkamp, Dick de Zeeuw, Pieter A de Graeff, et al.
Diabetologia|November 4, 2017
Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trialJelena P Seferovic, Marc A Pfeffer, Brian Claggett, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 18, 2015
Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled TrialGreg Fulcher, David R Matthews, Vlado Perkovic, et al.
Pageof 34